A novel RP-HPLC stability-indicating method for simultaneous estimation of Niraparib and Abiraterone in synthetic mixtures and combined tablet formulations
Abstract Niraparib and Abiraterone in a combined dosage form offer a fortunate regimen for treating cancers, mainly those resistant to conventional therapies cast in cancer treatment. The present study intends to develop a novel RP-HPLC method for simultaneously estimating Niraparib and Abiraterone...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer
2025-05-01
|
| Serier: | Discover Applied Sciences |
| Fag: | |
| Online adgang: | https://doi.org/10.1007/s42452-025-06930-5 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
